Blood Tests for Panhypopituitarism
To evaluate for panhypopituitarism, order the following blood tests: 8-9 AM serum cortisol, free T4 with TSH, testosterone/FSH/LH/prolactin (males before 10 AM fasting), estradiol/FSH/LH (females), and simultaneous serum and urine osmolality if polyuria is present. 1
Algorithmic Approach to Testing
1. Adrenal Axis (Central Adrenal Insufficiency)
First-line: 8-9 AM serum cortisol 1
- < 3 µg/dL: Confirms adrenal insufficiency
- > 15 µg/dL: Excludes adrenal insufficiency
- 3-15 µg/dL: Proceed to corticotropin stimulation test
Corticotropin stimulation test: Peak cortisol < 18.1 µg/dL (500 nmol/L) at 30 or 60 minutes indicates adrenal insufficiency 1
Critical timing: Perform testing at least 18-24 hours after last hydrocortisone dose (longer for synthetic glucocorticoids) 1
Common pitfall: Never use random cortisol levels for diagnosis—they are unreliable and should be avoided 1. Additionally, in acute-onset panhypopituitarism, initial cosyntropin testing may be falsely reassuring because the adrenal glands require approximately 2 weeks to atrophy after loss of ACTH secretion 2. If clinical suspicion remains high despite normal initial testing, repeat evaluation after 2 weeks.
2. Thyroid Axis (Central Hypothyroidism)
Order: Free T4 and TSH 1
- Diagnostic pattern: Low free T4 with low, normal, or mildly elevated TSH in the setting of pituitary disease confirms central hypothyroidism
- Low-normal free T4: If symptomatic, start levothyroxine or monitor over time; treat if free T4 decreases by ≥20% 1
Avoid: Dynamic TSH-secretion testing—it provides no useful diagnostic information 1
3. Gonadal Axis
Males (Central Hypogonadism)
- Order: Serum testosterone, FSH, LH, and prolactin 1
- Timing is critical: Before 10 AM, after overnight fast, and only when patient is not acutely/subacutely ill 1
- Diagnostic pattern: Low testosterone with inappropriately low or normal FSH/LH
Females (Central Hypogonadism)
Premenopausal with oligomenorrhea/amenorrhea: Measure estradiol, FSH, and LH 1
- Must exclude: Pregnancy, hyperprolactinemia, hyperandrogenism, and thyroid disease—particularly if no other pituitary deficits are present 1
Postmenopausal: Absence of elevated FSH and LH (when not on hormone replacement therapy) is sufficient for diagnosis 1
Avoid: GnRH dynamic testing—it offers no useful diagnostic information 1
Additional note: In women with panhypopituitarism, plasma testosterone levels are markedly decreased (mean 0.06 ng/mL vs normal 0.40 ng/mL) due to suppression of both adrenal and ovarian sources 3, though this is not routinely used for diagnosis.
4. Posterior Pituitary (Central Diabetes Insipidus)
- If polyuria present (>50 mL/kg/24h or >3.5 L/day in 70-kg person): Simultaneously measure serum and urine osmolality 1
- Diagnostic pattern: High serum osmolality (>295 mOsmol/L) with inappropriately dilute urine (osmolality failing to reach ~600 mOsmol/L; urine/plasma osmolality ratio <2)
- Confirm: Urine dipstick negative for glucose 1
Clinical pearl: In critically ill patients with septic shock, diabetes insipidus may be the first clue to panhypopituitarism and can manifest before adrenal insufficiency becomes apparent 2.
Key Caveats
Timing matters: The Endocrine Society guidelines emphasize that morning timing (8-9 AM for cortisol, before 10 AM for testosterone) is essential for accurate interpretation 1. Testing outside these windows significantly reduces diagnostic accuracy.
Avoid dynamic testing pitfalls: While the insulin tolerance test is considered the gold standard for assessing the HPA axis and growth hormone deficiency 4, the Endocrine Society guidelines focus on static measurements for initial screening. Reserve dynamic testing for equivocal cases or when considering growth hormone replacement.
Context is critical: Always interpret results in the clinical context. In acutely ill patients, initial testing may be misleading, and repeat evaluation may be necessary once the patient stabilizes 2.